Related Experiment Video
Updated: May 3, 2026

In Vitro Method to Control Concentrations of Halogenated Gases in Cultured Alveolar Epithelial Cells
Published on: October 23, 2018
Intravenous magnesium sulfate reduces rates of mechanical ventilation in pediatric asthma
Glenn Clinton Shedd1, Sarah M Noe
1Nell Hodgson Woodruff School of Nursing, Emory University, Atlanta, Georgia.
Abstract:
In this column, we examine an original research article by S. Torres et al. (2012) on the subject of magnesium sulfate use in pediatric patients with acute asthma. These researchers found that patients treated with 25 mg/kg of intravenous magnesium sulfate in addition to the conventional treatment options for acute asthma were less likely to require mechanical ventilation than patients in the control group. We review and critique this article and use a case study to illustrate the clinical implications of this research. We also examine some of the research and guidelines pertaining to the use of magnesium sulfate in acute asthma.
Related Concept Videos
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Skeletal Muscle Relaxants: Therapeutic Uses
Mechanical Ventilation I: Indication and Settings
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
